{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:09:16Z","timestamp":1763017756568},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.leukres.2017.05.011","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T17:01:37Z","timestamp":1494608497000},"page":"1-7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia"],"prefix":"10.1016","volume":"59","author":[{"given":"Jie","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Yong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu-Yi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Fa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.05.011_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bjh.12497","article-title":"Allogeneic transplantation in the UK: an aggregation of marginal gains","volume":"163","author":"Thomson","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.05.011_bib0010","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1182\/blood-2011-01-332007","article-title":"Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies","volume":"117","author":"Soiffer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.011_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/bbmt.2002.v8.pm11939603","article-title":"Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation","volume":"8","author":"Alyea","year":"2002","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.05.011_bib0020","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2004-05-1947","article-title":"Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age","volume":"105","author":"Alyea","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.011_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.011_bib0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/sim.6581","article-title":"Use of composite endpoints in clinical trials","volume":"35","author":"Sankoh","year":"2016","journal-title":"Stat. Med."},{"key":"10.1016\/j.leukres.2017.05.011_bib0035","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.011_bib0040","doi-asserted-by":"crossref","first-page":"32579","DOI":"10.18632\/oncotarget.8691","article-title":"Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT","volume":"7","author":"Xuan","year":"2016","journal-title":"Oncotarget"},{"issue":"August (15)","key":"10.1016\/j.leukres.2017.05.011_bib0045","first-page":"S0145","article-title":"Efficacy of cytarabine, aclarubicin and granulocyte colony-stimulating factor (CAG) regimen compared to FLAG regimen for adult patients with relapsed\/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia","author":"Li","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.05.011_bib0050","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bbmt.2009.06.017","article-title":"Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia","volume":"15","author":"Liu","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.05.011_bib0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197504242921706","article-title":"Bone-marrow transplantation (second of two parts)","volume":"292","author":"Thomas","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2017.05.011_bib0060","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: i. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.05.011_bib0065","doi-asserted-by":"crossref","first-page":"32579","DOI":"10.18632\/oncotarget.8691","article-title":"Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT","volume":"7","author":"Xuan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2017.05.011_bib0070","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.bbmt.2016.04.006","article-title":"Factors predicting graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation: multivariable analysis from a single center","volume":"22","author":"Solh","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.05.011_bib0075","doi-asserted-by":"crossref","first-page":"5143071","DOI":"10.1155\/2016\/5143071","article-title":"Prognostic factors on the graft-versus-host disease-free and relapse-free survival after adult allogeneic hematopoietic stem cell transplantation","volume":"2016","author":"Liu","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.leukres.2017.05.011_bib0080","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/bmt.2016.182","article-title":"Clinical separation of cGvHD and GvL and better GvHD-free\/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML","volume":"52","author":"Zheng","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.05.011_bib0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.011_bib0090","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1182\/blood-2011-02-339838","article-title":"Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome","volume":"118","author":"Lee","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.011_bib0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbmt.2009.02.001","article-title":"Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status","volume":"15","author":"Chang","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.05.011_bib0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/pbc.22159","article-title":"The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation","volume":"53","author":"Chang","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2017.05.011_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminhematol.2016.01.010","article-title":"HLA mismatching as a strategy to reduce relapse after alternative donor transplantation","volume":"53","author":"Fleischhauer","year":"2016","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.leukres.2017.05.011_bib0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/bmt.2014.223","article-title":"Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome","volume":"50","author":"Mo","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.leukres.2017.05.011_bib0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/leu.2015.232","article-title":"Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings","volume":"30","author":"Ringden","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.05.011_bib0120","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.05.011_bib0125","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1158\/1078-0432.CCR-15-2335","article-title":"Haploidentical versus matched-sibling transplant in adults with philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study","volume":"22","author":"Wang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2017.05.011_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/bjh.14331","article-title":"Similar incidence of severe acute GVHD and less severe chronic GVHD in PBSCT from unmanipulated, haploidentical donors compared with that from matched sibling donors for patients with haematological malignancies","volume":"176","author":"Li","year":"2017","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T02:59:46Z","timestamp":1719197986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617304319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":26,"alternative-id":["S0145212617304319"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.05.011","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}